Experimental · 5.4/10
VIP (Vasoactive Intestinal Peptide)
VIP, or vasoactive intestinal peptide, is the endogenous neuropeptide whose synthetic form is aviptadil, used off-label for anti-inflammatory, immune, respiratory, and erectile purposes. The mechanism and trial volume are real, but the two largest respiratory trials missed their primary endpoints, per Youssef 2022 and TESICO 2023, and the strongest positive randomized result is the niche erectile combination Invicorp, per Dinsmore 1999. Read the full breakdown →
The prediction game
Where does VIP (Vasoactive Intestinal Peptide) go in 12 months?
Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Be the first scout on record for VIP (Vasoactive Intestinal Peptide). Permanent credit on this page, plus points when your call resolves.
One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
Same as above — one verification covers all your entries here.
For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.